Literature DB >> 29872889

[Progressive renal insufficiency in a 55-year-old man with psoriasis].

K Herfurth1, M Busch1, H J Gröne2, G Wolf3.   

Abstract

Treatment with tumor necrosis factor alpha (TNF-α) inhibitors is a well-established therapeutic strategy for various autoimmune diseases. However, little is known about renal complications and possible causality of renal injury due to this treatment. The following case of a patient with psoriasis demonstrates the difficulties in classifying renal complications of anti-TNF-α therapy versus kidney involvement caused by the underlying disease.

Entities:  

Keywords:  Adalimumab; IgA glomerulonephritis; Prednisolone; Tumor necrosis factor-α inhibitors; Ustekinumab

Mesh：

Substances：

Year:  2018        PMID： 29872889     DOI： 10.1007/s00108-018-0446-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  10 in total

1.  IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of 'psoriatic nephropathy'.

Authors:  Josef Zadrazil; Tomás Tichý; Pavel Horák; Iva Nikorjaková; Pavel Zíma; Karel Krejcí; Pavel Strébl
Journal:  J Nephrol       Date:  2006 May-Jun       Impact factor: 3.902

2.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  Renal function in psoriasis patients.

Authors:  Nicoletta Cassano; Michela Vestita; Maria Panaro; Monica Carbonara; Gino A Vena
Journal:  Eur J Dermatol       Date:  2011 Mar-Apr       Impact factor: 3.328

4.  Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.

Authors:  P Menè; A-J Franeta; G Conti; A Stoppacciaro; R Chimenz; A Fede; R Gallizzi; C Fede
Journal:  Clin Exp Rheumatol       Date:  2010 Jan-Feb       Impact factor: 4.473

Review 5.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

6.  Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.

Authors:  Michael B Stokes; Kirk Foster; Glen S Markowitz; Farhang Ebrahimi; William Hines; Darren Kaufman; Brooke Moore; Daniel Wolde; Vivette D D'Agati
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

7.  Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.

Authors:  H-Y Chiu; H-L Huang; C-H Li; Y-J Yin; H-A Chen; S-T Hsu; S-J Lin; T-F Tsai; S-Y Ho
Journal:  Br J Dermatol       Date:  2015-05-12       Impact factor: 9.302

8.  [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].

Authors:  Hendrik Haake; Jens Köneke; Kerstin Amann; Jürgen vom Dahl; Ulf Janssen
Journal:  Med Klin (Munich)       Date:  2007-10-15

Review 9.  Autoimmune diseases induced by biological agents: a double-edged sword?

Authors:  Manuel Ramos-Casals; Candido Diaz-Lagares; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Autoimmun Rev       Date:  2009-10-23       Impact factor: 9.754

10.  [Antineutrophil cytoplasmic antibody associated vasculitis in a patient treated with adalimumab for a rheumatoid arthritis].

Authors:  Anne Fournier; Alain Nony; Khair Rifard
Journal:  Nephrol Ther       Date:  2009-05-30       Impact factor: 0.722
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.